OrbiMed’s Affimed AFMD Stock Holding History

OrbiMed’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-32,665	Closed	-$1.02M	–	126
2018 Q4	$1.02M	Hold	32,665	–	–	0.02%	122
2018 Q3	$1.42M	Hold	32,665	–	–	0.02%	143
2018 Q2	$539K	Hold	32,665	–	–	0.01%	143
2018 Q1	$604K	Hold	32,665	–	–	0.01%	136
2017 Q4	$425K	Hold	32,665	–	–	0.01%	129
2017 Q3	$735K	Sell	32,665 -147,305	-82%	-$3.19M	0.01%	134
2017 Q2	$3.69M	Sell	179,970 -21,920	-11%	-$487K	0.04%	123
2017 Q1	$4.64M	Sell	201,890 -135,610	-40%	-$2.98M	0.05%	118
2016 Q4	$6.08M	Hold	337,500	–	–	0.08%	106
2016 Q3	$9.38M	Sell	337,500 -40,000	-11%	-$1.12M	0.11%	102
2016 Q2	$9.36M	Sell	377,500 -15,680	-4%	-$573K	0.1%	93
2016 Q1	$14.7M	Sell	393,180 -65,082	-14%	-$2.45M	0.15%	71
2015 Q4	$32.6M	Hold	458,262	–	–	0.3%	62
2015 Q3	$28.3M	Sell	458,262 -123,201	-21%	-$15.3M	0.29%	62
2015 Q2	$78.3M	Hold	581,463	–	–	0.65%	47
2015 Q1	$36.6M	Hold	581,463	–	–	0.31%	63
2014 Q4	$36.1M	Hold	581,463	–	–	0.34%	60
2014 Q3	$36.6M	Buy	+581,463	New	+$36.3M	0.38%	52

Other funds holding AFMD

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

OrbiMed's AFMD Position: Q1 2019 in Review

OrbiMed sold out of Affimed (AFMD) in Q1 2019, closing a stake of 32,665 shares — an estimated $1.02M sold.

OrbiMed first reported a position in AFMD in Q3 2014 and held it in 18 quarters. The position peaked at $78.3M in Q2 2015. 55 funds tracked by Wall St. Rank hold AFMD as of Q1 2019.

OrbiMed reported no remaining Affimed position as of Q1 2019 after selling out during the quarter.
OrbiMed sold 32,665 Affimed shares in Q1 2019, an estimated $1.02M.
OrbiMed first reported a position in Affimed in Q3 2014 and held it in 18 quarters.
OrbiMed's Affimed position peaked at $78.3M in Q2 2015.
55 funds tracked by Wall St. Rank held Affimed as of Q1 2019.

Based on OrbiMed's 13F filing for Q1 2019, filed 15 May 2019.